• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    74 Biggest Movers From Yesterday

    6/3/22 5:50:47 AM ET
    $ACOR
    $AGLE
    $AHI
    $AI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACOR alert in real time by email

    Gainers

    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) shares gained 47.5% to settle at $0.8436 on Thursday. Based on the review of approximately 460 patients, Data Safety and Monitoring Board (DSMB) recently determined that the evaluation of NRx Pharmaceuticals’ Zyesami (aviptadil) should cease due to futility.
    • Repare Therapeutics Inc. (NASDAQ:RPTX) surged 44.8% to close at $12.67 on Thursday after the company announced it has entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of camonsertib. Repare will receive a $125 million upfront payment and is eligible to receive up to an additional $1.2 billion in potential milestones.
    • Talkspace, Inc. (NASDAQ:TALK) gained 34.4% to close at $1.76. Hearing Citibank said it believes that the company will be acquired.
    • EBET, Inc. (NASDAQ:EBET) rose 33.6% to settle at $3.68.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) jumped 29.2% to close at $2.39 after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
    • Credo Technology Group Holding Ltd (NASDAQ:CRDO) surged 26.2% to close at $12.94 after the company reported Q4 EPS results up from last year and better-than-expected sales results. The company also issued Q1 sales guidance above analyst estimates.
    • Avaya Holdings Corp. (NYSE:AVYA) surged 25.6% to close at $5.35.
    • Chewy, Inc. (NYSE:CHWY) jumped 24.2% to close at $29.18 after the company reported better-than-expected Q1 sales results.
    • Integrated Media Technology Limited (NASDAQ:IMTE) surged 23.7% to settle at $9.92.
    • The Singing Machine Company, Inc. (NASDAQ:MICS) gained 22.5% to close at $3.48.
    • Spruce Biosciences, Inc. (NASDAQ:SPRB) rose 20.6% to settle at $1.76. Spruce Biosciences was recently granted US patent 'Corticotropin Releasing Factor Receptor Antagonists.'
    • PyroGenesis Canada Inc. (NASDAQ:PYR) surged 19.9% to close at $3.07. PyroGenesis announced project to introduce plasma torches into the upstream anode baking process.
    • InnovAge Holding Corp. (NASDAQ:INNV) jumped 19.9% to close at $5.55.
    • American Superconductor Corporation (NASDAQ:AMSC) rose 19.7% to close at $6.32 following Q4 results.
    • Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) jumped 19.5% to settle at $5.22. Marinus Pharmaceuticals, last month, posted a Q1 loss of $0.52 per share.
    • Bon Natural Life Limited (NASDAQ:BON) gained 19.4% to close at $5.04.
    • Dunxin Financial Holdings Limited (NYSE:DXF) surged 19% to close at $0.5889.
    • Elastic N.V. (NYSE:ESTC) climbed 18.9% to close at $73.62 after the company reported better-than-expected Q4 EPS and sales results.
    • Heliogen, Inc. (NYSE:HLGN) gained 18.9% to settle at $4.53. Heliogen recently posted a Q1 loss of $0.32 per share.
    • MongoDB, Inc. (NASDAQ:MDB) climbed 18.6% to close at $286.70 after the company reported Q1 EPS results up from last year and better-than-expected sales results. The company also issued Q2 sales guidance above analysts’ estimates.
    • Pure Storage, Inc. (NYSE:PSTG) shares climbed 18.2% to close at $28.37 after the company reported better-than-expected Q1 financials results. The company also issued Q2 and FY23 sales guidance above analyst estimates.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 18.2% to close at $6.63 after declining over 16% on Wednesday.
    • Uranium Energy Corp. (NYSE:UEC) surged 18% to settle at $4.19.
    • RISE Education Cayman Ltd (NASDAQ:REDU) jumped 17.9% to close at $1.65.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) jumped 17.6% to close at $2.94.
    • Onconova Therapeutics, Inc. (NASDAQ:ONTX) gained 17.5% to close at $1.34.
    • Cytek Biosciences, Inc. (NASDAQ:CTKB) rose 17.2% to settle at $11.33. Cytek recently said it received CE Marking for series of cFluor Reagents, TBNK Kit.
    • GitLab Inc. (NASDAQ:GTLB) jumped 17.1% to close at $44.90.
    • MicroVision, Inc. (NASDAQ:MVIS) surged 16.9% to close at $4.01.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) gained 16.8% to close at $1.46.
    • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) jumped 16.8% to close at $3.48.
    • UiPath Inc. (NYSE:PATH) shares gained 16.7% to close at $19.64 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q3 and FY23 sales guidance above analysts’ estimates.
    • Nyxoah S.A. (NASDAQ:NYXH) rose 16.7% to close at $13.76.
    • Missfresh Limited (NASDAQ:MF) jumped 16.6% to close at $0.2857 after gaining over 51% on Wednesday.
    • Nu Holdings Ltd. (NYSE:NU) rose 16.2% to settle at $4.44.
    • KE Holdings Inc. (NYSE:BEKE) jumped 16% to close at $14.70. KE Holdings recently announced better-than-expected Q1 sales results.
    • Gevo, Inc. (NASDAQ:GEVO) climbed 15.9% to close at $4.74. Gevo, last month, reported better-than-expected Q1 sales results.
    • HashiCorp, Inc. (NASDAQ:HCP) gained 15.9% to close at $41.27. The company ppsted upbeat quarterly results.
    • Exscientia plc (NASDAQ:EXAI) rose 15.7% to settle at $13.54. Exscientia recently posted a Q1 loss of $0.41 per share.
    • electroCore, Inc. (NASDAQ:ECOR) surged 15.6% to close at $0.5955.
    • 111, Inc. (NASDAQ:YI) gained 15.6% to settle at $2.15.
    • Intrusion Inc. (NASDAQ:INTZ) rose 15.3% to close at $3.25. Intrusion reported a partnership with Innercore Technologies and multi-year deal.
    • Veeva Systems Inc. (NYSE:VEEV) gained 14.7% to close at $192.55 after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 and FY22 EPS guidance above analysts’ estimates.
    • Aqua Metals, Inc. (NASDAQ:AQMS) rose 14.4%to settle at $0.9434.
    • comScore, Inc. (NASDAQ:SCOR) rose 12.9% to close at $2.19. comScore Director Paul William Livek acquired a total of 600,000 shares at an average price of $1.92.
    • Lands' End, Inc. (NASDAQ:LE) gained 12.8% to close at $12.57 after the company reported better-than-expected Q1 EPS results.
    • Rain Therapeutics Inc. (NASDAQ:RAIN) jumped 12.7% to close at $2.75. Roth Capital initiated coverage on Rain Therapeutics with a Buy rating and announced a price target of $16.
    • Blue Apron Holdings, Inc. (NYSE:APRN) climbed 10.8% to settle at $3.40 after the company announced it will be offering a selection of meal kits without a subscription on Walmart.com.
    • Pineapple Energy Inc. (NASDAQ:PEGY) gained 10.1% to close at $2.30.

     

    Losers

    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) shares fell 51.3% to close at $0.73 on Thursday. Aeglea BioTherapeutics announced the U.S. Food and Drug Administration (FDA) has refused to accept the company’s Biologics License Application (BLA) with a Refusal to File (RTF) letter.
    • Immunic, Inc. (NASDAQ:IMUX) shares tumbled 46.8% to settle at $3.14 after the company reported data from its Phase 2 CALDOSE-1 trial of Vidofludimus Calcium did not achieve the primary endpoint.
    • Zosano Pharma Corporation (NASDAQ:ZSAN) dipped 43.2% to close at $1.00 after the company announced it filed a voluntary petition for relief under chapter 11.
    • Centessa Pharmaceuticals plc (NASDAQ:CNTA) fell 27.8% to close at $3.25 after the company announced it has made a strategic decision to discontinue development of lixivaptan for Autosomal Dominant Polycystic Kidney Disease including both the Phase 3 ACTION study and the open-label ALERT study.
    • CN Energy Group. Inc. (NASDAQ:CNEY) fell 26.3% to close at $1.51.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) dipped 25% to close at $0.3334.
    • Limelight Networks, Inc. (NASDAQ:LLNW) fell 16.1% to close at $2.92.
    • Innovid Corp. (NYSE:CTV) fell 15.5% to close at $2.99.
    • Genocea Biosciences, Inc. (NASDAQ:GNCA) dropped15% to close at $0.0510.
    • Nutex Health, Inc. (NASDAQ:NUTX) fell 14.5% to close at $9.21.
    • Gracell Biotechnologies Inc. (NASDAQ:GRCL) fell 14.4% to settle at $2.73. Cantor Fitzgerald recently initiated coverage on Gracell Biotechnologies with an Overweight rating and announced a price target of $20.
    • Mullen Automotive, Inc. (NASDAQ:MULN) fell 13.4% to close at $1.23. Mullen Automotive recently announced results of its solid-state polymer battery testing with the Battery Innovation Center in Indiana.
    • Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) shares fell 12.7% to close at $4.68 after the company priced its common stock offering of 10 million shares at $4.75 per share.
    • Histogen Inc. (NASDAQ:HSTO) shares fell 12.7% to close at $0.1371. Histogen reported a 1-for-20 reverse stock split.
    • WiSA Technologies, Inc. (NASDAQ:WISA) fell 12.6% to close at $0.70.
    • Lightwave Logic, Inc. (NASDAQ:LWLG) fell 12.5% to close at $6.94.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) dipped 12.5% to settle at $3.02.
    • Midatech Pharma plc (NASDAQ:MTP) dropped 12% to close at $0.66. The U.S. Food and Drug Administration (FDA) recently granted Fast Track Designation to Midatech Pharma PLC's (NASDAQ:MTP) lead drug candidate MTX110 for the treatment of patients with recurrent glioblastoma (rGBM).
    • Advanced Human Imaging Limited (NASDAQ:AHI) fell 9.3% to close at $0.7378.
    • Energy Focus, Inc. (NASDAQ:EFOI) fell 9% to close at $1.11 after jumping 37% on Wednesday.
    • CASI Pharmaceuticals, Inc. (NASDAQ:CASI) fell 8.6% to close at $3.71 following effect of 1:10 reverse stock split.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) fell 8.2% to close at $0.2619.
    • Conn's, Inc. (NASDAQ:CONN) fell 7.5% to close at $11.59. The company reported mixed results for its first quarter.
    • Hewlett Packard Enterprise Company (NYSE:HPE) fell 5.2% to close at $14.96 after the company reported worse-than-expected Q2 financials results. The company also issued Q3 and FY22 EPS guidance with midpoints below analyst estimates.
    • C3.ai, Inc. (NYSE:AI) shares fell 5% to close at $17.62 after the company issued Q1 and FY23 sales guidance below analyst estimates.
    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $AGLE
    $AHI
    $AI

    CompanyDatePrice TargetRatingAnalyst
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    C3.ai Inc.
    $AI
    2/26/2026Mkt Outperform → Mkt Perform
    Citizens
    MongoDB Inc.
    $MDB
    2/26/2026$455.00 → $400.00Outperform
    BMO Capital Markets
    Centessa Pharmaceuticals plc
    $CNTA
    2/24/2026$40.00Outperform
    Wolfe Research
    Credo Technology Group Holding Ltd
    $CRDO
    2/19/2026$165.00Buy
    Goldman
    Chewy Inc.
    $CHWY
    2/19/2026$28.00Mkt Perform → Outperform
    Raymond James
    Veeva Systems Inc.
    $VEEV
    2/17/2026$205.00Underweight → Equal-Weight
    Morgan Stanley
    Immix Biopharma Inc.
    $IMMX
    2/9/2026$14.00Outperform
    Mizuho
    More analyst ratings

    $ACOR
    $AGLE
    $AHI
    $AI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    May 13, 2021 - FDA In Brief: FDA Releases Investigation Report Following 2020 Salmonella Outbreak Linked to Red Onions

    For Immediate Release: May 13, 2021 The following quote is attributed to Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response “The FDA has been working with the CDC, state partners and Canadian officials to investigate the largest Salmonella Newport outbreak in over a decade, which was linked to red onions. The FDA, today, released a 2020 Salmonella Outbreak Linked to Red Onions Report that includes an o

    5/13/21 3:17:14 PM ET
    $INTZ
    Computer Communications Equipment
    Telecommunications

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Scott Anthony bought $2,126 worth of shares (2,175 units at $0.98), increasing direct ownership by 0.34% to 638,793 units (SEC Form 4)

    4 - INTRUSION INC (0000736012) (Issuer)

    1/12/26 7:57:35 AM ET
    $INTZ
    Computer Communications Equipment
    Telecommunications

    Chief Financial Officer Pinson Kimberly bought $2,444 worth of shares (2,500 units at $0.98), increasing direct ownership by 4% to 61,154 units (SEC Form 4)

    4 - INTRUSION INC (0000736012) (Issuer)

    1/12/26 7:58:01 AM ET
    $INTZ
    Computer Communications Equipment
    Telecommunications

    Chief Executive Officer Staples William bought $124,750 worth of shares (3,276 units at $38.08), increasing direct ownership by 0.96% to 345,671 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    1/5/26 6:26:25 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO & CFO Gupta Ashim was granted 288,321 shares, increasing direct ownership by 52% to 845,349 units (SEC Form 4)

    4 - UiPath, Inc. (0001734722) (Issuer)

    2/27/26 6:06:46 PM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    GC & Chief Legal Officer Brubaker Brad was granted 145,985 shares, increasing direct ownership by 24% to 747,634 units (SEC Form 4)

    4 - UiPath, Inc. (0001734722) (Issuer)

    2/27/26 6:05:58 PM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    Chief Accounting Officer Ramani Hitesh was granted 31,021 shares, increasing direct ownership by 19% to 193,829 units (SEC Form 4)

    4 - UiPath, Inc. (0001734722) (Issuer)

    2/27/26 6:04:33 PM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $AGLE
    $AHI
    $AI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Eos Energy downgraded by Guggenheim with a new price target

    Guggenheim downgraded Eos Energy from Buy to Neutral and set a new price target of $20.00

    2/27/26 8:28:11 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    C3.ai downgraded by Citizens

    Citizens downgraded C3.ai from Mkt Outperform to Mkt Perform

    2/26/26 7:10:22 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on MongoDB with a new price target

    BMO Capital Markets reiterated coverage of MongoDB with a rating of Outperform and set a new price target of $400.00 from $455.00 previously

    2/26/26 6:51:04 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $AGLE
    $AHI
    $AI
    SEC Filings

    View All

    SEC Form S-8 filed by Cytek Biosciences Inc.

    S-8 - Cytek Biosciences, Inc. (0001831915) (Filer)

    2/27/26 4:30:36 PM ET
    $CTKB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-Q filed by Elastic N.V.

    10-Q - Elastic N.V. (0001707753) (Filer)

    2/27/26 4:08:28 PM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    Ginkgo Bioworks Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer)

    2/26/26 9:56:36 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Publication relating to transparency notifications

    REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), February 27, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. Robert Taub / BMI Estate On February 26, 2026, Nyxoah received a transparency notification from Robert Taub and related person BMI Estate, following the passive crossing of a threshold. Based on the notification, Robert Taub (together with his controlled undertakings) holds 4,360,800 voting rights, consisting of 4,310,800 voting r

    2/27/26 4:30:00 PM ET
    $NYXH
    Medical/Dental Instruments
    Health Care

    Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

    Ginkgo provides an update on its fourth quarter financial resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA, ", Ginkgo", )) today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with additional details on the third quarter, as well as supplemental financial information will be available at investors.ginkgobioworks.com. Fourth Quarter 2025 Financial ResultsFourth quarter 2025 Total revenue of $33 million compared to $44 million in the comparable prior year pe

    2/26/26 4:26:00 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Elastic Reports Third Quarter Fiscal 2026 Financial Results

    Q3 Revenue of $450 million, up 18% year-over-year Elastic (NYSE:ESTC), the Search AI Company, announced financial results for its third quarter of fiscal 2026 ended January 31, 2026. Third Quarter Fiscal 2026 Financial Highlights Total revenue was $450 million, an increase of 18% year-over-year, or 16% on a constant currency basis Total subscription revenue was $426 million, an increase of 19% year-over-year, or 17% on a constant currency basis Sales-led subscription revenue (calculated as subscription revenue excluding Monthly Elastic Cloud) was $376 million, an increase of 21% year-over-year, or 19% on a constant currency basis Current remaining performance obligations wer

    2/26/26 4:05:00 PM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $AGLE
    $AHI
    $AI
    Leadership Updates

    Live Leadership Updates

    View All

    Chewy Appoints Chris Deppe as Chief Financial Officer

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a leading and trusted destination for pet parents and partners everywhere, announced today the appointment of Chris Deppe as Chief Financial Officer (CFO). Deppe is a seasoned finance and operations leader with more than 20 years of experience. He joined Chewy in 2022 as the Vice President of Supply Chain and Operations Finance, and most recently served as the Head of all Corporate and Commercial Finance Functions. During his tenure, he has played a key role in advancing the company's financial strategy, enhancing operational rigor, and supporting strong business performance aligned with Chewy's long-term strategic priorities. Prior to joining Chewy, D

    2/24/26 9:00:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Credo's Toucan PCIe Retimer Achieves PCI‑SIG® Compliance

    Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, announced that its PCIe® 6.0 technology-capable Toucan PCIe retimer has earned PCI-SIG® compliance at 32.0 GT/s. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210132002/en/Credo's PCIe® 6.0 technology-capable Toucan PCIe retimer has earned PCI-SIG® compliance at 32.0 GT/s. This validation enables customers to deploy Toucan confidently in PCIe 6.0 technology and previous generation systems, avoiding compatibility and debugging challenges common with legacy-onl

    2/10/26 9:00:00 AM ET
    $CRDO
    Semiconductors
    Technology

    Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.

    Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced that its Shareholders (as defined below) have approved the acquisition of all of the issued and outstanding common shares of the Company (the "Common Shares" and the holders of the Common Shares, the "Shareholders") by XenoTherapeutics, Inc. and Xeno Acquisition Corp. (jointly "Xeno") a non-profit biotechnology company, by way of a statutory plan of arrangement (the "Transaction" or the "Arrangement") at the special meeting of Shareholders held today (the "Meeting"). The special resolution approving the Arrangement was approved by: (i) 99.76% of the votes cast b

    1/16/26 4:58:00 PM ET
    $RPTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Financials

    Live finance-specific insights

    View All

    Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

    Ginkgo provides an update on its fourth quarter financial resultsBOSTON, Feb. 26, 2026 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA, ", Ginkgo", )) today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with additional details on the third quarter, as well as supplemental financial information will be available at investors.ginkgobioworks.com. Fourth Quarter 2025 Financial ResultsFourth quarter 2025 Total revenue of $33 million compared to $44 million in the comparable prior year pe

    2/26/26 4:26:00 PM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Elastic Reports Third Quarter Fiscal 2026 Financial Results

    Q3 Revenue of $450 million, up 18% year-over-year Elastic (NYSE:ESTC), the Search AI Company, announced financial results for its third quarter of fiscal 2026 ended January 31, 2026. Third Quarter Fiscal 2026 Financial Highlights Total revenue was $450 million, an increase of 18% year-over-year, or 16% on a constant currency basis Total subscription revenue was $426 million, an increase of 19% year-over-year, or 17% on a constant currency basis Sales-led subscription revenue (calculated as subscription revenue excluding Monthly Elastic Cloud) was $376 million, an increase of 21% year-over-year, or 19% on a constant currency basis Current remaining performance obligations wer

    2/26/26 4:05:00 PM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

    FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter and Full Year 2025 Highlights Total revenue for the fourth quarter was $62.1 million, an 8% increase compared to the fourth quarter of 2024, and the highest quarterly revenue achieved historically at CytekTotal revenue for the full year 2025 was $201.5 million, a 1% increase compared to the full year 2024Total recurring revenue, comprised of service and reagent revenues, grew 21% in 2025 compared to 2024, reaching 34% of

    2/26/26 4:05:00 PM ET
    $CTKB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ACOR
    $AGLE
    $AHI
    $AI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Stock Movement: Insider Purchase at electroCore Inc. on Jun 6

    **Analysis of Recent Insider Purchase at electroCore Inc.** An insider purchase was recently made at electroCore Inc. by Goldberger Daniel S on June 6, 2024. This transaction involved the purchase of $247,587 worth of shares, equating to 38,505 units at an average price of $6.43 per share. As a result of this purchase, Goldberger's direct ownership in the company increased by 18% to 249,565 units, as reported in the SEC Form 4 filing. Looking at the historical insider transactions at electroCore Inc., several interesting patterns emerge when analyzing the timing, price, volume, purchaser's role, and more. On August 8, 2023, Goldstein Julie Ann and Cuneo F Peter both filed SEC Form 4 report

    6/10/24 12:57:57 AM ET
    $ECOR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ACOR
    $AGLE
    $AHI
    $AI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Exscientia Plc

    SC 13G/A - Exscientia plc (0001865408) (Subject)

    11/22/24 9:11:55 PM ET
    $EXAI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Exscientia Plc

    SC 13D/A - Exscientia plc (0001865408) (Subject)

    11/22/24 8:00:16 PM ET
    $EXAI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care